One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study (Q34398108)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study
scientific article

    Statements

    One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study (English)
    Mark C Genovese
    Patrick Durez
    Hanno B Richards
    Jerzy Supronik
    Eva Dokoupilova
    Jacob A Aelion
    Sang-Heon Lee
    Christine E Codding
    Herbert Kellner
    Takashi Ikawa
    Sophie Hugot
    Gregory Ligozio
    Shephard Mpofu
    15 January 2014

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit